| NCT03217396 |
Biomarkers of Synaptic Damage in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03217396 |
Recruiting |
Neuromed IRCCS |
2020-09-01 |
| NCT04394871 |
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing |
https://ClinicalTrials.gov/show/NCT04394871 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-09-30 |
| NCT04283747 |
Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04283747 |
Recruiting |
Mazandaran University of Medical Sciences |
2022-10-31 |
| NCT04244916 |
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT04244916 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2023-05-01 |
| NCT02301572 |
Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course |
https://ClinicalTrials.gov/show/NCT02301572 |
Completed |
Weill Medical College of Cornell University |
2016-07-31 |
| NCT03662347 |
Patient Acceptable Symptomatic State and Minimal Clinically Important Difference of the Fatigue in Multiple Sclerosis (SeDiF_SEP) |
https://ClinicalTrials.gov/show/NCT03662347 |
Recruiting |
Central Hospital, Nancy, France |
2022-03-31 |
| NCT03408093 |
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b |
https://ClinicalTrials.gov/show/NCT03408093 |
Completed |
Bayer |
2010-03-30 |
| NCT03401307 |
Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03401307 |
Active, not recruiting |
University of Southern Denmark |
2020-07-31 |
| NCT03396822 |
Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03396822 |
Recruiting |
University of Maryland, Baltimore |
2020-09-30 |
| NCT03382392 |
Hypermetabolism in ALS Using Six REE Formulas |
https://ClinicalTrials.gov/show/NCT03382392 |
Completed |
University Hospital, Limoges |
2014-11-30 |
| NCT03378375 |
Resting Energy Expenditure Equations in Amyotrophic Lateral Sclerosis, Creation of a ALS-specific Equation |
https://ClinicalTrials.gov/show/NCT03378375 |
Completed |
University Hospital, Limoges |
2014-11-30 |
| NCT01776060 |
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study |
https://ClinicalTrials.gov/show/NCT01776060 |
Active, not recruiting |
Duke University |
2020-12-31 |
| NCT04057222 |
Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04057222 |
Completed |
Pierre and Marie Curie University |
2019-09-06 |
| NCT01817361 |
Oral Health and People With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT01817361 |
Completed |
University of Alabama at Birmingham |
2010-06-30 |
| NCT03826095 |
Respiratory Functions, Trunk Control and Mobility Evaluation in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03826095 |
Completed |
Hacettepe University |
2019-07-26 |
| NCT03825055 |
Resilience in Young Adults Newly Diagnosed With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03825055 |
Recruiting |
Universita di Verona |
2022-03-31 |
| NCT03340194 |
Evaluation of Calcinosis in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03340194 |
Active, not recruiting |
University Hospital, Lille |
2020-06-30 |
| NCT03313843 |
Study to Assess OCT: RNFL and GCL in MS Patients |
https://ClinicalTrials.gov/show/NCT03313843 |
Recruiting |
Tampa Bay Uveitis Center, LLC |
2022-12-31 |
| NCT03302442 |
Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03302442 |
Completed |
Nantes University Hospital |
2017-08-01 |
| NCT03297580 |
Itch and Clinacal Caracteristics in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03297580 |
Completed |
University Hospital, Brest |
2016-03-31 |
| NCT03291756 |
Corrona Multiple Sclerosis (MS) Registry |
https://ClinicalTrials.gov/show/NCT03291756 |
Enrolling by invitation |
Corrona, LLC. |
2100-12-31 |
| NCT03284970 |
Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes |
https://ClinicalTrials.gov/show/NCT03284970 |
Completed |
EMD Serono |
2018-05-11 |
| NCT03281330 |
Effect of Motor Entrainment to Auditory Cues and Music During Walking on Quality of Movement and Perceived Fatigue in Persons With Multiple Sclerosis (PwMS) |
https://ClinicalTrials.gov/show/NCT03281330 |
Completed |
Hasselt University |
2018-05-30 |
| NCT03276195 |
Studies in Patients With Tuberous Sclerosis Complex |
https://ClinicalTrials.gov/show/NCT03276195 |
Recruiting |
Translational Genomics Research Institute |
2020-12-31 |
| NCT03271320 |
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03271320 |
Completed |
University Hospital, Lille |
2018-03-31 |
| NCT03268330 |
Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03268330 |
Recruiting |
Assiut University |
2020-10-31 |
| NCT03255460 |
The Relationship Between Fatigue and Physical Activity Level in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03255460 |
Completed |
Gazi University |
2018-07-04 |
| NCT03250169 |
Neurofilaments for NEDA Assessing in MS |
https://ClinicalTrials.gov/show/NCT03250169 |
Recruiting |
Queen Mary University of London |
2020-07-01 |
| NCT03225144 |
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia |
https://ClinicalTrials.gov/show/NCT03225144 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-10-30 |
| NCT04455542 |
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT04455542 |
Completed |
Peking University Third Hospital |
2019-05-01 |
| NCT03216915 |
Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03216915 |
Recruiting |
Universitätsklinikum Hamburg-Eppendorf |
2019-12-31 |
| NCT03209479 |
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) “Prevention of Relapse of Multiple Sclerosis” |
https://ClinicalTrials.gov/show/NCT03209479 |
Recruiting |
Takeda |
2025-03-31 |
| NCT03205280 |
Clinical Decision Support System (CADIMS) for MS Diagnostic |
https://ClinicalTrials.gov/show/NCT03205280 |
Recruiting |
Rennes University Hospital |
2020-03-01 |
| NCT03204747 |
Effect of Need to Void on Gait Speed in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03204747 |
Completed |
Pierre and Marie Curie University |
2017-08-31 |
| NCT03191669 |
Vaccine Exposure in Patients With MS |
https://ClinicalTrials.gov/show/NCT03191669 |
Completed |
Hospices Civils de Lyon |
2017-07-07 |
| NCT03157830 |
Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab |
https://ClinicalTrials.gov/show/NCT03157830 |
Recruiting |
Providence Health & Services |
2021-06-30 |
| NCT03134573 |
Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study |
https://ClinicalTrials.gov/show/NCT03134573 |
Completed |
Bayer |
2018-05-09 |
| NCT03122873 |
Quantitation of McArdle’s Sign and Evaluation of Specificity for Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03122873 |
Completed |
Mayo Clinic |
2017-06-30 |
| NCT03111394 |
Study of myMS in Participants With a Diagnosis of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03111394 |
Active, not recruiting |
University of Southern California |
2020-12-31 |
| NCT03108573 |
Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters |
https://ClinicalTrials.gov/show/NCT03108573 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2013-07-31 |
| NCT03087136 |
A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil |
https://ClinicalTrials.gov/show/NCT03087136 |
Recruiting |
Pontificia Universidade Católica do Rio Grande do Sul |
2019-03-31 |
| NCT03073239 |
Amyotrophic Lateral Sclerosis: a New Paradigm |
https://ClinicalTrials.gov/show/NCT03073239 |
Completed |
Conde, Bebiana, M.D. |
2018-03-31 |
| NCT03067025 |
Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03067025 |
Completed |
The Hospital for Sick Children |
2019-09-16 |
| NCT03052595 |
Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance |
https://ClinicalTrials.gov/show/NCT03052595 |
Recruiting |
Slovak Academy of Sciences |
2020-06-30 |
| NCT03033355 |
Central Nervous System Changes Following BotulinumtoxinA Injection in the Bladder |
https://ClinicalTrials.gov/show/NCT03033355 |
Completed |
The Methodist Hospital System |
2019-03-31 |
| NCT03025269 |
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03025269 |
Enrolling by invitation |
University at Buffalo |
2021-04-30 |
| NCT03004794 |
Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis Cohort |
https://ClinicalTrials.gov/show/NCT03004794 |
Completed |
Cairo University |
2016-08-31 |
| NCT03004079 |
Clinical Importance of Glucose Regulation in Relapsing MS |
https://ClinicalTrials.gov/show/NCT03004079 |
Recruiting |
University of Virginia |
2020-09-30 |
| NCT04454892 |
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT04454892 |
Recruiting |
Peking University Third Hospital |
2030-12-01 |
| NCT02966808 |
Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02966808 |
Recruiting |
Hospital General Universitario Gregorio Marañon |
2020-12-31 |
| NCT02921035 |
Non-interventional Study to Assess Adherence to Treatment for Patients With Relapsing Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02921035 |
Active, not recruiting |
Merck KGaA, Darmstadt, Germany |
2020-06-30 |
| NCT02907281 |
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02907281 |
Completed |
Novartis |
2017-07-24 |
| NCT02913209 |
Quantitative Fatigue and Muscle Performance in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02913209 |
Active, not recruiting |
Washington D.C. Veterans Affairs Medical Center |
2018-10-31 |
| NCT02898974 |
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02898974 |
Completed |
Colorado State University |
2017-10-31 |
| NCT02896933 |
Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02896933 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2015-01-31 |
| NCT02893683 |
Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT02893683 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2017-05-15 |
| NCT02893605 |
Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT02893605 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2017-05-31 |
| NCT02887781 |
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France |
https://ClinicalTrials.gov/show/NCT02887781 |
Recruiting |
University Hospital, Brest |
2020-12-31 |
| NCT02887352 |
French Adaptation of the California Card Sorting Task (CCST) in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02887352 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2020-01-31 |
| NCT02869360 |
Correlation Between PET and Advanced MRI in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02869360 |
Completed |
University of British Columbia |
2019-10-02 |
| NCT02852278 |
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale |
https://ClinicalTrials.gov/show/NCT02852278 |
Completed |
University of South Florida |
2019-09-13 |
| NCT02836327 |
Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders |
https://ClinicalTrials.gov/show/NCT02836327 |
Recruiting |
Chinese PLA General Hospital |
2019-09-30 |
| NCT02845635 |
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02845635 |
Recruiting |
Duke University |
2025-08-31 |
| NCT02814487 |
MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment. |
https://ClinicalTrials.gov/show/NCT02814487 |
Completed |
Ad scientiam |
2016-09-30 |
| NCT02795897 |
Genomic Translation for Amyotrophic Lateral Sclerosis Care |
https://ClinicalTrials.gov/show/NCT02795897 |
Recruiting |
Columbia University |
2019-09-30 |
| NCT02789670 |
Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT02789670 |
Recruiting |
University Hospital, Lille |
2020-07-31 |
| NCT02776072 |
Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) |
https://ClinicalTrials.gov/show/NCT02776072 |
Completed |
Biogen |
2016-12-31 |
| NCT02749396 |
EPID Multiple Sclerosis Pregnancy Study |
https://ClinicalTrials.gov/show/NCT02749396 |
Completed |
Bayer |
2018-08-14 |
| NCT02740296 |
Depression and Immune Function in Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT02740296 |
Completed |
Charite University, Berlin, Germany |
2017-06-30 |
| NCT02695394 |
Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study |
https://ClinicalTrials.gov/show/NCT02695394 |
Completed |
Charite University, Berlin, Germany |
2016-12-31 |
| NCT02686268 |
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS |
https://ClinicalTrials.gov/show/NCT02686268 |
Completed |
Washington University School of Medicine |
2017-12-31 |
| NCT02686684 |
Tecfidera Diffusion Tensor Imaging |
https://ClinicalTrials.gov/show/NCT02686684 |
Completed |
University at Buffalo |
2016-10-31 |
| NCT02679885 |
Teriflunomide Male Transmission Study |
https://ClinicalTrials.gov/show/NCT02679885 |
Completed |
Griffin Hospital |
2018-08-31 |
| NCT02675075 |
DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS |
https://ClinicalTrials.gov/show/NCT02675075 |
Completed |
VA Office of Research and Development |
2017-12-31 |
| NCT02664324 |
MSPT Device Usability Study |
https://ClinicalTrials.gov/show/NCT02664324 |
Completed |
Biogen |
2016-04-30 |
| NCT02659956 |
Pathological Basis of MRI Signal Changes in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02659956 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2041-02-26 |
| NCT02651545 |
Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02651545 |
Recruiting |
State University of New York at Buffalo |
2020-11-15 |
| NCT02612935 |
An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02612935 |
Completed |
Lumos Labs, Inc. |
2017-02-28 |
| NCT02611674 |
Methodology Study of Novel Outcome Measures to Assess Progression of ALS |
https://ClinicalTrials.gov/show/NCT02611674 |
Completed |
Biogen |
2018-07-27 |
| NCT02592265 |
Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden |
https://ClinicalTrials.gov/show/NCT02592265 |
Completed |
Lille Catholic University |
2015-08-31 |
| NCT02588053 |
Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)? |
https://ClinicalTrials.gov/show/NCT02588053 |
Completed |
University of Colorado, Denver |
2018-12-31 |
| NCT02582385 |
In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT02582385 |
Completed |
Brugmann University Hospital |
2015-02-28 |
| NCT02572479 |
Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS) |
https://ClinicalTrials.gov/show/NCT02572479 |
Completed |
University of Jena |
2018-10-31 |
| NCT01617395 |
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility |
https://ClinicalTrials.gov/show/NCT01617395 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02567136 |
Imaging Biomarkers in ALS |
https://ClinicalTrials.gov/show/NCT02567136 |
Active, not recruiting |
University of Minnesota |
2025-09-30 |
| NCT00493298 |
Tysabri Observational Program |
https://ClinicalTrials.gov/show/NCT00493298 |
Active, not recruiting |
Biogen |
2029-01-03 |
| NCT02559869 |
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT02559869 |
Completed |
Massachusetts General Hospital |
2019-06-28 |
| NCT02559765 |
Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK. |
https://ClinicalTrials.gov/show/NCT02559765 |
Completed |
University of Glasgow |
2015-11-30 |
| NCT02549703 |
Mitochondrial Dysfunction and Disease Progression |
https://ClinicalTrials.gov/show/NCT02549703 |
Completed |
Icahn School of Medicine at Mount Sinai |
2018-09-27 |
| NCT02528071 |
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT02528071 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2021-04-30 |
| NCT02519413 |
Tecfidera Lymphocyte Chart Review |
https://ClinicalTrials.gov/show/NCT02519413 |
Completed |
Biogen |
2016-02-29 |
| NCT02507713 |
Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT02507713 |
Completed |
Universidad Católica San Antonio de Murcia |
2014-04-30 |
| NCT02504840 |
Natural History of Multiple Sclerosis and Its Mimickers |
https://ClinicalTrials.gov/show/NCT02504840 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-03-18 |
| NCT02486640 |
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon |
https://ClinicalTrials.gov/show/NCT02486640 |
Completed |
Bayer |
2019-10-31 |
| NCT02486562 |
iConquerMSâ„¢ - A Patient-Powered Research Network for Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02486562 |
Recruiting |
Accelerated Cure Project for Multiple Sclerosis |
2026-10-31 |
| NCT02461459 |
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC) |
https://ClinicalTrials.gov/show/NCT02461459 |
Recruiting |
Boston Children’s Hospital |
2024-12-31 |
| NCT02440126 |
Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk |
https://ClinicalTrials.gov/show/NCT02440126 |
Recruiting |
Rocky Mountain MS Research Group, LLC |
2017-03-31 |
| NCT02433028 |
Swiss Multiple Sclerosis Cohort-Study |
https://ClinicalTrials.gov/show/NCT02433028 |
Recruiting |
University Hospital, Basel, Switzerland |
2042-01-31 |
| NCT02418897 |
Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02418897 |
Completed |
Texas Tech University Health Sciences Center |
2016-11-30 |
| NCT02405182 |
MRI Biomarkers in ALS |
https://ClinicalTrials.gov/show/NCT02405182 |
Completed |
University of Alberta |
2019-03-31 |
| NCT02398149 |
Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02398149 |
Completed |
Mount Sinai Rehabilitation Hospital |
2016-10-31 |
| NCT02383550 |
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension |
https://ClinicalTrials.gov/show/NCT02383550 |
Completed |
Clinique Neuro-Outaouais |
2017-08-30 |
| NCT02367222 |
A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrixâ„¢ in Manitoba, Canada |
https://ClinicalTrials.gov/show/NCT02367222 |
Completed |
University of Manitoba |
2015-08-31 |
| NCT02365922 |
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) |
https://ClinicalTrials.gov/show/NCT02365922 |
Recruiting |
University of California, San Francisco |
2020-09-30 |
| NCT02369224 |
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics |
https://ClinicalTrials.gov/show/NCT02369224 |
Completed |
Brown, Theodore R., M.D., MPH |
2016-02-29 |
| NCT02346279 |
Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists |
https://ClinicalTrials.gov/show/NCT02346279 |
Completed |
Institut fuer Physiotherapieforschung |
2013-10-31 |
| NCT02339441 |
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT02339441 |
Completed |
University of Manchester |
2015-12-31 |
| NCT02327845 |
Phenotype, Genotype & Biomarkers in ALS and Related Disorders |
https://ClinicalTrials.gov/show/NCT02327845 |
Recruiting |
University of Miami |
2021-06-30 |
| NCT02331225 |
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02331225 |
Completed |
Louisiana State University Health Sciences Center in New Orleans |
2016-07-31 |
| NCT02330965 |
Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02330965 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-07-12 |
| NCT02325375 |
sCD163 in ALS Patients |
https://ClinicalTrials.gov/show/NCT02325375 |
Completed |
University of Aarhus |
2016-02-29 |
| NCT02308670 |
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02308670 |
Completed |
University at Buffalo |
2016-10-31 |
| NCT02308579 |
Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases |
https://ClinicalTrials.gov/show/NCT02308579 |
Completed |
University at Buffalo |
2015-03-31 |
| NCT02313285 |
A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 |
https://ClinicalTrials.gov/show/NCT02313285 |
Active, not recruiting |
Sanofi |
2022-04-30 |
| NCT02307877 |
Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate |
https://ClinicalTrials.gov/show/NCT02307877 |
Active, not recruiting |
University of Colorado, Denver |
2020-03-31 |
| NCT02277964 |
Disease Control in RRMS Transferring Treatment From Natalizumab to Fingolimod |
https://ClinicalTrials.gov/show/NCT02277964 |
Completed |
University Hospital, Basel, Switzerland |
2016-08-31 |
| NCT02275741 |
Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02275741 |
Completed |
University of Rostock |
2015-09-30 |
| NCT02247310 |
BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon |
https://ClinicalTrials.gov/show/NCT02247310 |
Completed |
Bayer |
2016-07-19 |
| NCT02230969 |
Plegridy Observational Program |
https://ClinicalTrials.gov/show/NCT02230969 |
Active, not recruiting |
Biogen |
2022-01-20 |
| NCT02207075 |
Measuring Active Microglia in Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02207075 |
Active, not recruiting |
Weill Medical College of Cornell University |
2020-06-30 |
| NCT02157064 |
Outcomes Data of Adipose Stem Cells to Treat Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02157064 |
Active, not recruiting |
StemGenex |
2019-05-31 |
| NCT02159573 |
Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab) |
https://ClinicalTrials.gov/show/NCT02159573 |
Completed |
Biogen |
2015-01-31 |
| NCT02137707 |
Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya |
https://ClinicalTrials.gov/show/NCT02137707 |
Completed |
McGill University |
2017-11-30 |
| NCT02139696 |
Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation |
https://ClinicalTrials.gov/show/NCT02139696 |
Completed |
Turku University Hospital |
2015-01-31 |
| NCT02137109 |
Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri |
https://ClinicalTrials.gov/show/NCT02137109 |
Completed |
Biogen |
2015-10-31 |
| NCT02118298 |
Allocentric Memory in MS and Resting State Functional MRI |
https://ClinicalTrials.gov/show/NCT02118298 |
Completed |
Yale University |
2016-04-30 |
| NCT02105818 |
Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT02105818 |
Completed |
University Hospital, Basel, Switzerland |
2014-06-30 |
| NCT02099370 |
Adherence to Treatment With Tecfideraâ„¢ in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT02099370 |
Completed |
University of South Florida |
2016-01-31 |
| NCT02082002 |
Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - Ticino |
https://ClinicalTrials.gov/show/NCT02082002 |
Completed |
Ospedale Civico, Lugano |
2018-12-21 |
| NCT02076841 |
Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen |
https://ClinicalTrials.gov/show/NCT02076841 |
Completed |
Biogen |
2016-02-29 |
| NCT01285479 |
Pregnancy Registry Trial |
https://ClinicalTrials.gov/show/NCT01285479 |
Recruiting |
Novartis |
2030-07-31 |
| NCT01281657 |
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program |
https://ClinicalTrials.gov/show/NCT01281657 |
Completed |
Novartis |
2012-07-31 |
| NCT01272596 |
Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01272596 |
Completed |
Charite University, Berlin, Germany |
2013-11-30 |
| NCT01270425 |
Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT01270425 |
Completed |
Meir Medical Center |
2011-12-31 |
| NCT01271699 |
Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01271699 |
Completed |
Centogene AG Rostock |
2019-12-01 |
| NCT03360188 |
Pediatric Onset Multiple Sclerosis in Egyptians |
https://ClinicalTrials.gov/show/NCT03360188 |
Completed |
Cairo University |
2015-12-31 |
| NCT04036097 |
Prospective Stratification of Infectious Risks in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04036097 |
Recruiting |
University Hospital, Basel, Switzerland |
2022-04-30 |
| NCT02017808 |
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months |
https://ClinicalTrials.gov/show/NCT02017808 |
Completed |
University at Buffalo |
2014-12-31 |
| NCT03357887 |
Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome |
https://ClinicalTrials.gov/show/NCT03357887 |
Active, not recruiting |
Centre Hospitalier Universitaire de NÄ«mes |
2020-12-31 |
| NCT00794352 |
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System |
https://ClinicalTrials.gov/show/NCT00794352 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02008669 |
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02008669 |
Completed |
Lille Catholic University |
2017-06-09 |
| NCT01993004 |
Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells |
https://ClinicalTrials.gov/show/NCT01993004 |
Completed |
Rutgers, The State University of New Jersey |
2015-12-31 |
| NCT01977287 |
Walking With FES or AFO in People With MS With Foot Drop |
https://ClinicalTrials.gov/show/NCT01977287 |
Completed |
Queen Margaret University |
2016-03-31 |
| NCT02965170 |
Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS |
https://ClinicalTrials.gov/show/NCT02965170 |
Completed |
Rocky Mountain MS Research Group, LLC |
2017-12-31 |
| NCT01945359 |
Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design |
https://ClinicalTrials.gov/show/NCT01945359 |
Completed |
Rocky Mountain MS Research Group, LLC |
2014-09-30 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01925196 |
Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation |
https://ClinicalTrials.gov/show/NCT01925196 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT01909492 |
Relaxin in Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT01909492 |
Recruiting |
Providence Health & Services |
2019-09-30 |
| NCT01903291 |
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS |
https://ClinicalTrials.gov/show/NCT01903291 |
Completed |
Biogen |
2016-02-29 |
| NCT01889043 |
Monitoring of Non-invasive Ventilation During Sleep in ALS |
https://ClinicalTrials.gov/show/NCT01889043 |
Completed |
Universitaire Ziekenhuizen Leuven |
2015-09-30 |
| NCT01851434 |
Natural History of Optic Neuritis |
https://ClinicalTrials.gov/show/NCT01851434 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-09-05 |
| NCT01848418 |
Conception of an ICF Core Set for Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT01848418 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2018-03-31 |
| NCT01846234 |
Sodium Intake in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01846234 |
Completed |
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia |
2013-07-31 |
| NCT01847287 |
A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years |
https://ClinicalTrials.gov/show/NCT01847287 |
Completed |
University at Buffalo |
2013-02-28 |
| NCT01804647 |
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease |
https://ClinicalTrials.gov/show/NCT01804647 |
Completed |
GeNeuro Innovation SAS |
2015-02-28 |
| NCT01780441 |
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) |
https://ClinicalTrials.gov/show/NCT01780441 |
Active, not recruiting |
Boston Children’s Hospital |
2019-12-31 |
| NCT01774123 |
Optical Coherence Tomography in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT01774123 |
Completed |
The Cleveland Clinic |
2013-06-30 |
| NCT01772888 |
Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients? |
https://ClinicalTrials.gov/show/NCT01772888 |
Completed |
University Hospital, Geneva |
2019-07-31 |
| NCT01767779 |
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC |
https://ClinicalTrials.gov/show/NCT01767779 |
Completed |
University of Alabama at Birmingham |
2016-12-31 |
| NCT01749943 |
Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01749943 |
Completed |
Brown, Theodore R., M.D., MPH |
2013-07-31 |
| NCT04185688 |
The Reliability and Validity of the Functional Reach Test in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04185688 |
Completed |
Gazi University |
2020-02-07 |
| NCT01737372 |
A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01737372 |
Completed |
Rocky Mountain MS Research Group, LLC |
2016-10-31 |
| NCT01723709 |
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort |
https://ClinicalTrials.gov/show/NCT01723709 |
Completed |
Duke University |
2017-05-31 |
| NCT01711255 |
Evaluation of Coagulation in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01711255 |
Completed |
Bastyr University |
2016-05-31 |
| NCT01703429 |
Complementary and Alternative Care in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01703429 |
Recruiting |
Bastyr University |
2030-06-30 |
| NCT01704183 |
Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01704183 |
Completed |
Kuopio University Hospital |
2014-03-31 |
| NCT01695434 |
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months |
https://ClinicalTrials.gov/show/NCT01695434 |
Completed |
University at Buffalo |
2013-02-28 |
| NCT01673633 |
Sacroiliitis in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT01673633 |
Completed |
Cukurova University |
NA |
| NCT01626248 |
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control |
https://ClinicalTrials.gov/show/NCT01626248 |
Completed |
Rocky Mountain MS Research Group, LLC |
2013-03-31 |
| NCT01628315 |
Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study |
https://ClinicalTrials.gov/show/NCT01628315 |
Completed |
University at Buffalo |
2009-03-31 |
| NCT01601119 |
Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients |
https://ClinicalTrials.gov/show/NCT01601119 |
Completed |
Merck KGaA, Darmstadt, Germany |
2014-07-31 |
| NCT01601080 |
An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device |
https://ClinicalTrials.gov/show/NCT01601080 |
Completed |
Merck KGaA, Darmstadt, Germany |
2012-10-31 |
| NCT01592552 |
A Biospecimen and Clinical Data Study on Patients With Alzheimer’s, Multiple Sclerosis, Parkinson’s, and Huntington’s, for Drug & Biomarker Discovery |
https://ClinicalTrials.gov/show/NCT01592552 |
Completed |
Sanguine Biosciences |
2015-03-31 |
| NCT01592474 |
Evaluation of Brain Atrophy in CIS Patients on Avonex |
https://ClinicalTrials.gov/show/NCT01592474 |
Completed |
University at Buffalo |
2011-08-31 |
| NCT01596881 |
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01596881 |
Completed |
Oregon Health and Science University |
2017-02-08 |
| NCT01592097 |
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS |
https://ClinicalTrials.gov/show/NCT01592097 |
Completed |
University of Southern California |
2018-04-30 |
| NCT01592084 |
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT01592084 |
Completed |
The Methodist Hospital System |
2011-09-30 |
| NCT01587690 |
Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells |
https://ClinicalTrials.gov/show/NCT01587690 |
Completed |
Rutgers, The State University of New Jersey |
2013-01-31 |
| NCT01547351 |
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire |
https://ClinicalTrials.gov/show/NCT01547351 |
Completed |
Mallinckrodt |
2012-09-30 |
| NCT01547234 |
Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01547234 |
Completed |
Carmel Medical Center |
2014-12-31 |
| NCT01535664 |
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT01535664 |
Completed |
Acorda Therapeutics |
2012-05-31 |
| NCT01508962 |
PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT01508962 |
Active, not recruiting |
University of Miami |
2027-12-31 |
| NCT01495390 |
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers |
https://ClinicalTrials.gov/show/NCT01495390 |
Completed |
Massachusetts General Hospital |
2016-12-31 |
| NCT01492023 |
The Effects of Attention Retraining in MS |
https://ClinicalTrials.gov/show/NCT01492023 |
Completed |
Finnish MS Society |
2012-04-30 |
| NCT01491100 |
Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01491100 |
Completed |
Bayer |
2016-12-22 |
| NCT01489748 |
Canadian Avonex PEN Productivity Study |
https://ClinicalTrials.gov/show/NCT01489748 |
Completed |
Biogen |
2014-10-31 |
| NCT01485003 |
Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants |
https://ClinicalTrials.gov/show/NCT01485003 |
Completed |
Biogen |
2018-11-26 |
| NCT01468792 |
Hemodynamic Changes in Connective Tissue Disease |
https://ClinicalTrials.gov/show/NCT01468792 |
Completed |
Medical University of Graz |
2014-02-28 |
| NCT01459302 |
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders |
https://ClinicalTrials.gov/show/NCT01459302 |
Recruiting |
University of Massachusetts, Worcester |
2021-10-31 |
| NCT01456416 |
Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities |
https://ClinicalTrials.gov/show/NCT01456416 |
Completed |
University of Southern California |
2013-04-30 |
| NCT01442194 |
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies |
https://ClinicalTrials.gov/show/NCT01442194 |
Recruiting |
Novartis |
NA |
| NCT01436838 |
China Betaferon Adherence, Coping and Nurse Support Study |
https://ClinicalTrials.gov/show/NCT01436838 |
Completed |
Bayer |
2015-09-30 |
| NCT01414816 |
Betaferon® Regulatory Post-Marketing Surveillance |
https://ClinicalTrials.gov/show/NCT01414816 |
Completed |
Bayer |
2012-07-31 |
| NCT01396343 |
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01396343 |
Completed |
University of California, San Francisco |
2018-04-30 |
| NCT01399957 |
Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT01399957 |
Completed |
Mount Sinai Rehabilitation Hospital |
2014-09-30 |
| NCT01384825 |
Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases |
https://ClinicalTrials.gov/show/NCT01384825 |
Completed |
Fondazione Italiana Sclerosi Multipla |
2012-09-30 |
| NCT01377090 |
Digital Ulceration |
https://ClinicalTrials.gov/show/NCT01377090 |
Completed |
Actelion |
2012-07-31 |
| NCT03787446 |
PET Study in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03787446 |
Recruiting |
University of British Columbia |
2020-03-31 |
| NCT01366040 |
Avonex PEN Satisfaction and Patients Experience Clinical Trial |
https://ClinicalTrials.gov/show/NCT01366040 |
Completed |
Biogen |
2012-05-31 |
| NCT01356134 |
Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI) |
https://ClinicalTrials.gov/show/NCT01356134 |
Completed |
Genetic Disease Investigators |
2015-04-30 |
| NCT01353547 |
Genes and Environment in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01353547 |
Recruiting |
Columbia University |
2040-10-31 |
| NCT01354665 |
Depression and Fatigue in MS Patients Treated With Betaferon. |
https://ClinicalTrials.gov/show/NCT01354665 |
Completed |
Bayer |
2013-06-30 |
| NCT04450030 |
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04450030 |
Recruiting |
University Hospital Muenster |
2020-08-31 |
| NCT04446325 |
Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT04446325 |
Recruiting |
University Hospital, Brest |
2020-09-01 |
| NCT04438954 |
Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels |
https://ClinicalTrials.gov/show/NCT04438954 |
Completed |
Ankara Yildirim Beyazıt University |
2020-06-05 |
| NCT04411498 |
Frequency of Fibromyalgia Syndrome in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT04411498 |
Completed |
Antalya Training and Research Hospital |
2019-12-20 |
| NCT04408742 |
Relationship Between Pain, Anxiety and Fatigue and Knee Position Sense, Balance and Dual Task Performance During Menstrual Cycle in Females With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04408742 |
Completed |
Ankara Yildirim Beyazıt University |
2019-10-20 |
| NCT04386863 |
Taxonomy of Neurorehabilitation Treatments and Outcome Measures: a Multicentre Italian Study |
https://ClinicalTrials.gov/show/NCT04386863 |
Recruiting |
Fondazione Don Carlo Gnocchi Onlus |
2020-07-07 |
| NCT04363684 |
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) |
https://ClinicalTrials.gov/show/NCT04363684 |
Recruiting |
Mayo Clinic |
2024-07-31 |
| NCT04301596 |
Assessment of Nutritional Status in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT04301596 |
Recruiting |
University Hospital, Montpellier |
2023-06-12 |
| NCT04288011 |
Validation of the BeCare Multiple Sclerosis Assessment App |
https://ClinicalTrials.gov/show/NCT04288011 |
Enrolling by invitation |
BeCare Link LLC |
2021-08-26 |
| NCT04283071 |
Kinematic Assessment In Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04283071 |
Recruiting |
The Leeds Teaching Hospitals NHS Trust |
2021-05-01 |
| NCT04286828 |
Position Sense, Balance, and Dual Task Performance at the Menstrual Cycle in Females With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04286828 |
Completed |
Ankara Yildirim Beyazıt University |
2019-10-20 |
| NCT04265092 |
Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04265092 |
Completed |
Pôle Saint Hélier |
2014-03-31 |
| NCT04252599 |
Upper Airway Function and Cardiorespiratory Performance in Impair Trunk Motor Control Multiple Sclerosis Patients. |
https://ClinicalTrials.gov/show/NCT04252599 |
Recruiting |
Universidad de Granada |
2019-12-02 |
| NCT04240379 |
Metacognition Assessment in Patient With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04240379 |
Recruiting |
University Hospital, Grenoble |
2021-08-31 |
| NCT03438032 |
Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD |
https://ClinicalTrials.gov/show/NCT03438032 |
Recruiting |
Northwestern University |
2020-02-01 |
| NCT04233099 |
Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS) |
https://ClinicalTrials.gov/show/NCT04233099 |
Recruiting |
Fondazione Don Carlo Gnocchi Onlus |
2020-03-30 |
| NCT04231253 |
MUltiple Sclerosis : T Cell / B Cell Exploration |
https://ClinicalTrials.gov/show/NCT04231253 |
Recruiting |
Rennes University Hospital |
2023-02-28 |
| NCT04228328 |
Validity and Reliability of the 6-minute Walk Test Over a Distance of 6 Metres in People With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04228328 |
Recruiting |
Haute Ecole de Santé Vaud |
2021-01-30 |
| NCT04221191 |
Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP |
https://ClinicalTrials.gov/show/NCT04221191 |
Recruiting |
Biogen |
2021-08-19 |
| NCT04219592 |
IgG-4 Levels in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT04219592 |
Active, not recruiting |
Meir Medical Center |
2019-09-30 |
| NCT04210960 |
Correlation of Serum Lactate and Activity of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04210960 |
Recruiting |
Mansoura University Hospital |
2020-05-01 |
| NCT04183751 |
The Relationship Between Kinesiophobia, Physical Activity, Balance and Fear of Fall in MS Patients |
https://ClinicalTrials.gov/show/NCT04183751 |
Recruiting |
Marmara University |
2020-04-21 |
| NCT04153773 |
OCT and Early Cognitive Impairment in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04153773 |
Completed |
Mansoura University Hospital |
2019-06-01 |
| NCT04148313 |
A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04148313 |
Recruiting |
ProgenaBiome |
2023-03-31 |
| NCT04150809 |
A Study to Explore the Role of Gut Flora in ALS |
https://ClinicalTrials.gov/show/NCT04150809 |
Recruiting |
ProgenaBiome |
2023-03-31 |
| NCT04132206 |
Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT04132206 |
Recruiting |
Hôpital Européen Marseille |
2022-10-08 |
| NCT04133779 |
Observational Study on Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04133779 |
Completed |
Fondazione Italiana Sclerosi Multipla |
2012-05-30 |
| NCT04132037 |
An Observational Study on Intermittent Self Catheterisation Discontinuation Factors in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT04132037 |
Active, not recruiting |
University Hospital, Toulouse |
2021-12-31 |
| NCT04131673 |
MS and NMOSD in African-Americans |
https://ClinicalTrials.gov/show/NCT04131673 |
Enrolling by invitation |
University of Kentucky |
2023-12-31 |
| NCT04123353 |
Scan-Rescan Sub-Study of MS PATHS |
https://ClinicalTrials.gov/show/NCT04123353 |
Completed |
Biogen |
2017-05-09 |
| NCT04112537 |
Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship |
https://ClinicalTrials.gov/show/NCT04112537 |
Active, not recruiting |
University Hospital, Montpellier |
2019-12-30 |
| NCT04097158 |
Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone |
https://ClinicalTrials.gov/show/NCT04097158 |
Recruiting |
Loma Linda University |
2021-09-30 |
| NCT04082468 |
VALIDATE: Factor VIII Trending for MS Relapse |
https://ClinicalTrials.gov/show/NCT04082468 |
Recruiting |
St. Joseph’s Hospital and Medical Center, Phoenix |
2021-12-01 |
| NCT04075968 |
The Effect of Cognitive Group Exercise Combined With Physical Exercise in MS |
https://ClinicalTrials.gov/show/NCT04075968 |
Completed |
Istanbul Physical Medicine Rehabilitation Training and Research Hospital |
2019-11-15 |
| NCT04063852 |
PTNS on Urinary and Global Quality of Life in MS Patients |
https://ClinicalTrials.gov/show/NCT04063852 |
Recruiting |
University of Michigan |
2021-12-31 |
| NCT04053374 |
Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04053374 |
Recruiting |
University College, London |
2020-06-30 |
| NCT04024969 |
DiagnosE Using the Central veIn SIgn |
https://ClinicalTrials.gov/show/NCT04024969 |
Recruiting |
Nottingham University Hospitals NHS Trust |
2022-05-31 |
| NCT04022564 |
Incidence, and Survival Medical Expenditure of Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04022564 |
Active, not recruiting |
China Medical University Hospital |
2020-05-20 |
| NCT04024085 |
Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04024085 |
Recruiting |
Pierre and Marie Curie University |
2019-07-31 |
| NCT04008329 |
A Registered Cohort Study on Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT04008329 |
Recruiting |
First Affiliated Hospital of Fujian Medical University |
2029-07-31 |
| NCT03347370 |
A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03347370 |
Completed |
Biogen |
2019-07-31 |
| NCT03981003 |
Serum Neurofilament-light Chain Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03981003 |
Recruiting |
Centre Hospitalier Universitaire de NÄ«mes |
2023-06-30 |
| NCT03945006 |
Balance, Trunk Impairment and Fear of Falling in Multiple Sclerosis Patients With Incontinence |
https://ClinicalTrials.gov/show/NCT03945006 |
Completed |
Ankara Yildirim Beyazıt University |
2019-04-20 |
| NCT03941184 |
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity |
https://ClinicalTrials.gov/show/NCT03941184 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT03942952 |
PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes. |
https://ClinicalTrials.gov/show/NCT03942952 |
Recruiting |
University of Texas Southwestern Medical Center |
2022-05-31 |
| NCT03937271 |
Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03937271 |
Active, not recruiting |
Taipei Veterans General Hospital, Taiwan |
2019-05-31 |
| NCT03933215 |
A Study of Suboptimally Controlled Participants Previously Taking Injectable Disease-modifying Drugs (DMDs) for Relapsing Forms of Multiple Sclerosis (RMS) |
https://ClinicalTrials.gov/show/NCT03933215 |
Recruiting |
EMD Serono |
2023-11-29 |
| NCT03933202 |
A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion Disease-Modifying Drugs (DMDs) for Relapsing Forms of Multiple Sclerosis (RMS) |
https://ClinicalTrials.gov/show/NCT03933202 |
Recruiting |
EMD Serono |
2023-05-03 |
| NCT03927092 |
Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire |
https://ClinicalTrials.gov/show/NCT03927092 |
Completed |
Ege University |
2016-05-31 |
| NCT03926637 |
Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03926637 |
Recruiting |
Biogen |
2022-09-01 |
| NCT03912987 |
TRIAL READY (Clinical Trial Readiness) |
https://ClinicalTrials.gov/show/NCT03912987 |
Recruiting |
University of Miami |
2022-01-31 |
| NCT03893344 |
STAT4 in Multiple Sclerosis by PCR and Flow Cytometry |
https://ClinicalTrials.gov/show/NCT03893344 |
Completed |
Assiut University |
2020-05-20 |
| NCT03889509 |
A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03889509 |
Active, not recruiting |
Lawson Health Research Institute |
2020-03-01 |
| NCT03873389 |
Ocrelizumab Effects on the Metabolome in MS |
https://ClinicalTrials.gov/show/NCT03873389 |
Recruiting |
Johns Hopkins University |
2023-01-31 |
| NCT03854123 |
Multiple Sclerosis in the Elderly: Epidemiology, Clinical and MRI Characteristics |
https://ClinicalTrials.gov/show/NCT03854123 |
Recruiting |
University Hospital, Bordeaux |
2020-12-31 |
| NCT03841903 |
Spinal Cord Analysis in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03841903 |
Completed |
University Hospital, Basel, Switzerland |
2020-03-24 |
| NCT03816189 |
Role of Eosinophil in Fibrogenesis of Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03816189 |
Recruiting |
University Hospital, Lille |
2020-12-31 |
| NCT03806647 |
Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1) |
https://ClinicalTrials.gov/show/NCT03806647 |
Recruiting |
Taipei Veterans General Hospital, Taiwan |
2020-04-01 |
| NCT03808142 |
PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon |
https://ClinicalTrials.gov/show/NCT03808142 |
Completed |
Bayer |
2020-04-20 |
| NCT03796247 |
Alexithymia Frequency and Interhemispheric Transfer in Patients With a First Demyelinating Event |
https://ClinicalTrials.gov/show/NCT03796247 |
Completed |
University Hospital, Lille |
2016-05-31 |
| NCT02994121 |
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region |
https://ClinicalTrials.gov/show/NCT02994121 |
Recruiting |
University of Pittsburgh |
2047-01-31 |
| NCT03784547 |
Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM |
https://ClinicalTrials.gov/show/NCT03784547 |
Recruiting |
Hospital Italiano de Buenos Aires |
2019-08-01 |
| NCT03764384 |
Validation Of Tidal/End -Tidal CO2 in ALS |
https://ClinicalTrials.gov/show/NCT03764384 |
Active, not recruiting |
Papworth Hospital NHS Foundation Trust |
2020-06-04 |
| NCT03757065 |
Cell Surface Marker Expression in Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT03757065 |
Enrolling by invitation |
Alpine Immune Sciences, Inc. |
2020-03-31 |
| NCT03736902 |
Views on Physical Activity Following a Relapse in People With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03736902 |
Completed |
City, University of London |
2019-05-14 |
| NCT03723356 |
Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT03723356 |
Recruiting |
NYU Langone Health |
2021-12-13 |
| NCT03718247 |
Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS |
https://ClinicalTrials.gov/show/NCT03718247 |
Recruiting |
University of Virginia |
2022-10-31 |
| NCT03718026 |
The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03718026 |
Completed |
Gazi University |
2018-11-16 |
| NCT03678987 |
Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03678987 |
Completed |
Region Skane |
2020-01-01 |
| NCT03656055 |
Analysis of Neurodegenerative Process Within Visual Ways In Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03656055 |
Recruiting |
University Hospital, Lille |
2019-12-31 |
| NCT03655093 |
Validation of a Self-questionnaire in French on the Use of the Upper Limbs in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03655093 |
Completed |
Rennes University Hospital |
2017-07-03 |
| NCT03653585 |
Cortical Lesions in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03653585 |
Recruiting |
Danish Research Centre for Magnetic Resonance |
2020-07-31 |
| NCT03632473 |
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03632473 |
Recruiting |
University Hospital, Basel, Switzerland |
2022-07-31 |
| NCT03601520 |
Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03601520 |
Completed |
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy |
2017-10-31 |
| NCT03597451 |
The Effects of Muscles Strength on Physical Performance in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03597451 |
Completed |
Gazi University |
2020-02-28 |
| NCT03593590 |
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03593590 |
Recruiting |
Hoffmann-La Roche |
2025-07-26 |
| NCT03594357 |
Cognitive Functions in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03594357 |
Completed |
Gazi University |
2018-12-21 |
| NCT03586986 |
Risk Factors in Early Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03586986 |
Recruiting |
University of Colorado, Denver |
2020-05-30 |
| NCT03579017 |
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study |
https://ClinicalTrials.gov/show/NCT03579017 |
Recruiting |
Haukeland University Hospital |
2021-12-31 |
| NCT03577977 |
Betaferon Use in Children and Adolescents With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03577977 |
Completed |
Bayer |
2009-04-15 |
| NCT03578796 |
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study |
https://ClinicalTrials.gov/show/NCT03578796 |
Recruiting |
Haukeland University Hospital |
2021-12-31 |
| NCT03562975 |
Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus |
https://ClinicalTrials.gov/show/NCT03562975 |
Recruiting |
University of South Florida |
2020-08-31 |
| NCT03566797 |
Secondary Sclerosis Cholangitis Prospective |
https://ClinicalTrials.gov/show/NCT03566797 |
Recruiting |
Medical University of Graz |
2021-06-01 |
| NCT03560661 |
Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT03560661 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2019-12-23 |
| NCT03543956 |
Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition |
https://ClinicalTrials.gov/show/NCT03543956 |
Completed |
University Hospital, Bordeaux |
2019-06-27 |
| NCT03508284 |
Dual-Task Performance in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03508284 |
Completed |
Gazi University |
2019-05-16 |
| NCT03464448 |
Mechanistic Studies of Teriflunomide in RRMS |
https://ClinicalTrials.gov/show/NCT03464448 |
Recruiting |
University of Michigan |
2021-10-31 |
| NCT03451175 |
Reproductibility of Cystometry in Multiple Sclerosis Patient |
https://ClinicalTrials.gov/show/NCT03451175 |
Completed |
Pierre and Marie Curie University |
2017-11-01 |
| NCT03449212 |
SOD1 Kinetics Measurements in ALS Patients |
https://ClinicalTrials.gov/show/NCT03449212 |
Recruiting |
Washington University School of Medicine |
2020-05-31 |
| NCT03438357 |
Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI |
https://ClinicalTrials.gov/show/NCT03438357 |
Active, not recruiting |
Centre Hospitalier Universitaire de NÄ«mes |
2020-11-30 |
| NCT01235455 |
Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors |
https://ClinicalTrials.gov/show/NCT01235455 |
Completed |
Bayer |
NA |
| NCT01233245 |
BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program |
https://ClinicalTrials.gov/show/NCT01233245 |
Completed |
Bayer |
2009-06-30 |
| NCT01207648 |
Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY) |
https://ClinicalTrials.gov/show/NCT01207648 |
Completed |
EMD Serono |
2011-07-31 |
| NCT01206023 |
Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples |
https://ClinicalTrials.gov/show/NCT01206023 |
Completed |
Carmel Medical Center |
2011-11-30 |
| NCT01195870 |
Assessment of Patient Use of a New Device: RebiSmart |
https://ClinicalTrials.gov/show/NCT01195870 |
Completed |
Merck KGaA, Darmstadt, Germany |
2010-09-30 |
| NCT01195857 |
Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration |
https://ClinicalTrials.gov/show/NCT01195857 |
Completed |
Merck KGaA, Darmstadt, Germany |
2009-09-30 |
| NCT01184833 |
Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01184833 |
Completed |
Bayer |
NA |
| NCT01185717 |
JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT01185717 |
Completed |
Biogen |
2012-05-31 |
| NCT01157728 |
Early Cognitive Impairment in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01157728 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-12-31 |
| NCT01158183 |
Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01158183 |
Completed |
Bayer |
2009-09-30 |
| NCT01142583 |
A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01142583 |
Completed |
Merck KGaA, Darmstadt, Germany |
2009-08-31 |
| NCT01142557 |
An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01142557 |
Completed |
Merck KGaA, Darmstadt, Germany |
2005-11-30 |
| NCT01143428 |
Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study |
https://ClinicalTrials.gov/show/NCT01143428 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01142518 |
An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone |
https://ClinicalTrials.gov/show/NCT01142518 |
Completed |
Merck KGaA, Darmstadt, Germany |
2009-03-31 |
| NCT01142492 |
A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®) |
https://ClinicalTrials.gov/show/NCT01142492 |
Completed |
Merck KGaA, Darmstadt, Germany |
2008-07-31 |
| NCT01141751 |
An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy |
https://ClinicalTrials.gov/show/NCT01141751 |
Completed |
Merck KGaA, Darmstadt, Germany |
2011-06-30 |
| NCT01142453 |
An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients |
https://ClinicalTrials.gov/show/NCT01142453 |
Completed |
Merck KGaA, Darmstadt, Germany |
2008-06-30 |
| NCT01128075 |
Treatment Adherence When Using RebiSmartâ„¢ in Relapsing Multiple Sclerosis Subjects |
https://ClinicalTrials.gov/show/NCT01128075 |
Completed |
Merck KGaA, Darmstadt, Germany |
2014-04-30 |
| NCT01125475 |
A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects |
https://ClinicalTrials.gov/show/NCT01125475 |
Completed |
Merck KGaA, Darmstadt, Germany |
2012-03-31 |
| NCT01118130 |
Pharmacogenomics of Drug Safety in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01118130 |
Recruiting |
University of British Columbia |
2020-12-31 |
| NCT01112657 |
An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period |
https://ClinicalTrials.gov/show/NCT01112657 |
Completed |
Merck KGaA, Darmstadt, Germany |
2014-10-31 |
| NCT01112345 |
An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters |
https://ClinicalTrials.gov/show/NCT01112345 |
Completed |
Merck KGaA, Darmstadt, Germany |
2012-09-30 |
| NCT01108887 |
An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™. |
https://ClinicalTrials.gov/show/NCT01108887 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-01-31 |
| NCT01110993 |
An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF) |
https://ClinicalTrials.gov/show/NCT01110993 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-09-30 |
| NCT01101776 |
Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. |
https://ClinicalTrials.gov/show/NCT01101776 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-04-30 |
| NCT01084798 |
A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years |
https://ClinicalTrials.gov/show/NCT01084798 |
Completed |
Merck KGaA, Darmstadt, Germany |
2008-12-31 |
| NCT01080053 |
Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT01080053 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-05-31 |
| NCT01080573 |
Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01080573 |
Completed |
Merck KGaA, Darmstadt, Germany |
2011-04-30 |
| NCT01080040 |
To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT01080040 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-03-31 |
| NCT01080027 |
Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR) |
https://ClinicalTrials.gov/show/NCT01080027 |
Completed |
Merck KGaA, Darmstadt, Germany |
2011-06-30 |
| NCT01076595 |
Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period |
https://ClinicalTrials.gov/show/NCT01076595 |
Completed |
Bayer |
2013-11-30 |
| NCT01080014 |
Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina |
https://ClinicalTrials.gov/show/NCT01080014 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-04-30 |
| NCT01075880 |
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif® |
https://ClinicalTrials.gov/show/NCT01075880 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-06-30 |
| NCT01080001 |
A Observational, Prospective Study to Assess the Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in Argentina |
https://ClinicalTrials.gov/show/NCT01080001 |
Completed |
Merck KGaA, Darmstadt, Germany |
2010-12-31 |
| NCT01075737 |
An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers |
https://ClinicalTrials.gov/show/NCT01075737 |
Completed |
Merck KGaA, Darmstadt, Germany |
2011-03-31 |
| NCT01079975 |
To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01079975 |
Completed |
Merck KGaA, Darmstadt, Germany |
2010-10-31 |
| NCT01074346 |
Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01074346 |
Completed |
Merck KGaA, Darmstadt, Germany |
2011-11-30 |
| NCT01070836 |
JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab |
https://ClinicalTrials.gov/show/NCT01070836 |
Completed |
Biogen |
2015-11-30 |
| NCT01070823 |
JC-Virus (JCV) Antibody Program |
https://ClinicalTrials.gov/show/NCT01070823 |
Completed |
Biogen |
2012-06-30 |
| NCT01070719 |
Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort |
https://ClinicalTrials.gov/show/NCT01070719 |
Completed |
Rocky Mountain MS Research Group, LLC |
2010-05-31 |
| NCT01067573 |
The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment |
https://ClinicalTrials.gov/show/NCT01067573 |
Completed |
University of South Florida |
NA |
| NCT01044576 |
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01044576 |
Completed |
Imperial College London |
2012-11-30 |
| NCT01031459 |
Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial. |
https://ClinicalTrials.gov/show/NCT01031459 |
Completed |
Bayer |
2010-12-31 |
| NCT01034644 |
Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15) |
https://ClinicalTrials.gov/show/NCT01034644 |
Completed |
Merck KGaA, Darmstadt, Germany |
2010-11-30 |
| NCT01020370 |
Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies |
https://ClinicalTrials.gov/show/NCT01020370 |
Completed |
Wayne State University |
NA |
| NCT01013350 |
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials |
https://ClinicalTrials.gov/show/NCT01013350 |
Completed |
EMD Serono |
2018-10-25 |
| NCT00963833 |
Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00963833 |
Completed |
Bayer |
2016-04-12 |
| NCT00958672 |
Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule Endoscopy |
https://ClinicalTrials.gov/show/NCT00958672 |
Completed |
University Hospital, Rouen |
2011-09-30 |
| NCT00956501 |
Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00956501 |
Completed |
Atrium Health |
2010-02-28 |
| NCT00937677 |
Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study |
https://ClinicalTrials.gov/show/NCT00937677 |
Completed |
University at Buffalo |
2009-12-31 |
| NCT00928967 |
Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT00928967 |
Completed |
Bayer |
2010-03-31 |
| NCT00919217 |
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms |
https://ClinicalTrials.gov/show/NCT00919217 |
Recruiting |
University of Louisville |
2020-12-31 |
| NCT00888277 |
Bayer/Cognitive Assessments With Multiple Sclerosis Subjects |
https://ClinicalTrials.gov/show/NCT00888277 |
Completed |
University of Louisville |
2009-12-31 |
| NCT00902135 |
Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH) |
https://ClinicalTrials.gov/show/NCT00902135 |
Completed |
Bayer |
2013-12-31 |
| NCT00884481 |
Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS |
https://ClinicalTrials.gov/show/NCT00884481 |
Completed |
Biogen |
2011-06-30 |
| NCT00882453 |
Physical Activity and Fatigue in Early Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT00882453 |
Completed |
Bayer |
2011-03-31 |
| NCT00873340 |
Physical Disability in Patients Treated With Betaferon |
https://ClinicalTrials.gov/show/NCT00873340 |
Completed |
Bayer |
2011-01-31 |
| NCT00859482 |
Differential Immune Effects of Natalizumab |
https://ClinicalTrials.gov/show/NCT00859482 |
Completed |
Cantonal Hospital of St. Gallen |
2007-07-31 |
| NCT00853788 |
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil |
https://ClinicalTrials.gov/show/NCT00853788 |
Completed |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2011-06-30 |
| NCT00843102 |
Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT00843102 |
Completed |
University of Pecs |
2009-12-31 |
| NCT00838617 |
Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00838617 |
Completed |
Vanderbilt University |
2009-08-31 |
| NCT04338646 |
Is the Severity of Urinary Disorders Related to Falls in People With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT04338646 |
Recruiting |
Pierre and Marie Curie University |
2020-04-15 |
| NCT04157283 |
Sexual Dysfunction in Patients With Relapsing Remitting Multiple Sclerosis and Associated Comorbidities |
https://ClinicalTrials.gov/show/NCT04157283 |
Recruiting |
Mansoura University Hospital |
2020-05-05 |
| NCT02880553 |
Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02880553 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2017-03-09 |
| NCT02654340 |
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) |
https://ClinicalTrials.gov/show/NCT02654340 |
Recruiting |
Centogene AG Rostock |
2023-12-30 |
| NCT02021162 |
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT02021162 |
Completed |
University at Buffalo |
2018-09-30 |
| NCT04131764 |
Diagnosis of ON With or Without MS or NMOSD |
https://ClinicalTrials.gov/show/NCT04131764 |
Enrolling by invitation |
University of Kentucky |
2021-12-31 |
| NCT03975413 |
Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03975413 |
Active, not recruiting |
Rush University Medical Center |
2020-04-01 |
| NCT02623946 |
Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT02623946 |
Active, not recruiting |
Clinique Neuro-Outaouais |
2020-12-31 |
| NCT01948102 |
Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples |
https://ClinicalTrials.gov/show/NCT01948102 |
Completed |
Atrium Health |
2014-08-06 |
| NCT00821132 |
Genetics of Familial and Sporadic ALS |
https://ClinicalTrials.gov/show/NCT00821132 |
Recruiting |
Northwestern University |
2019-12-31 |
| NCT01418924 |
Sex Hormones & Serum Sclerostin Level |
https://ClinicalTrials.gov/show/NCT01418924 |
Completed |
Bagcilar Training and Research Hospital |
2011-09-30 |
| NCT01366027 |
PRISM Registry: Pseudobulbar Affect Registry Series |
https://ClinicalTrials.gov/show/NCT01366027 |
Completed |
Avanir Pharmaceuticals |
2012-09-30 |
| NCT02011204 |
Study of Electrical Impedance Myography (EIM) in ALS |
https://ClinicalTrials.gov/show/NCT02011204 |
Completed |
Skulpt, Inc. |
2016-03-31 |
| NCT00809224 |
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00809224 |
Completed |
University of Michigan |
2012-05-31 |
| NCT01766063 |
Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon |
https://ClinicalTrials.gov/show/NCT01766063 |
Completed |
Bayer |
2017-01-09 |
| NCT01706055 |
Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE) |
https://ClinicalTrials.gov/show/NCT01706055 |
Completed |
Bayer |
2015-09-30 |
| NCT03756142 |
Biomechanical Characterization of the Locomotion in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT03756142 |
Recruiting |
Lille Catholic University |
2020-11-05 |
| NCT03489278 |
Clinical Procedures to Support Research in ALS |
https://ClinicalTrials.gov/show/NCT03489278 |
Recruiting |
University of Miami |
2024-06-30 |
| NCT03332654 |
Stress Urinary Incontinence in Women With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03332654 |
Completed |
Lille Catholic University |
2016-01-31 |
| NCT03187847 |
Rehabilitation in Multiple Sclerosis - Sometimes Too Much? |
https://ClinicalTrials.gov/show/NCT03187847 |
Completed |
Klinik Valens |
2018-03-30 |
| NCT03134716 |
Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT03134716 |
Active, not recruiting |
Turku University Hospital |
2022-04-30 |
| NCT03088839 |
Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT03088839 |
Recruiting |
Neuromed IRCCS |
2019-09-01 |
| NCT02869048 |
Amyotrophic Lateral Sclerosis and the Innate Immune System |
https://ClinicalTrials.gov/show/NCT02869048 |
Recruiting |
Rigshospitalet, Denmark |
2026-06-30 |
| NCT02598167 |
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition |
https://ClinicalTrials.gov/show/NCT02598167 |
Completed |
Hoffmann-La Roche |
2016-02-23 |
| NCT02287948 |
Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects |
https://ClinicalTrials.gov/show/NCT02287948 |
Completed |
University Hospital of Ferrara |
2015-12-31 |
| NCT01881191 |
Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months |
https://ClinicalTrials.gov/show/NCT01881191 |
Completed |
University at Buffalo |
2015-10-31 |
| NCT01804660 |
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population |
https://ClinicalTrials.gov/show/NCT01804660 |
Completed |
GeNeuro Innovation SAS |
2013-11-30 |
| NCT01658384 |
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT01658384 |
Completed |
Clinique Neuro-Outaouais |
2015-02-28 |
| NCT04371575 |
Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients |
https://ClinicalTrials.gov/show/NCT04371575 |
Completed |
Danish Headache Center |
2019-12-31 |
| NCT03486665 |
Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients. |
https://ClinicalTrials.gov/show/NCT03486665 |
Recruiting |
Bioimmunate |
2018-09-30 |
| NCT00812474 |
Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00812474 |
Completed |
Sunnybrook Health Sciences Centre |
2009-06-30 |
| NCT00786032 |
A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients |
https://ClinicalTrials.gov/show/NCT00786032 |
Completed |
VA Office of Research and Development |
2013-06-30 |
| NCT00718497 |
Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population |
https://ClinicalTrials.gov/show/NCT00718497 |
Completed |
Drexel University |
2012-05-31 |
| NCT00718458 |
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00718458 |
Completed |
Drexel University |
2016-12-31 |
| NCT00716131 |
Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program |
https://ClinicalTrials.gov/show/NCT00716131 |
Completed |
Drexel University |
2016-11-30 |
| NCT00718393 |
Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00718393 |
Completed |
Drexel University |
2015-10-31 |
| NCT00714636 |
Cerebrospinal Fluid Repository |
https://ClinicalTrials.gov/show/NCT00714636 |
Completed |
Drexel University |
2008-10-31 |
| NCT00714805 |
Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00714805 |
Completed |
Drexel University |
2016-11-30 |
| NCT00704834 |
Gene Expression Profiles in Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT00704834 |
Completed |
University of California, Davis |
2017-07-05 |
| NCT00704626 |
Serum Auto-Antibodies in Neurological Diseases |
https://ClinicalTrials.gov/show/NCT00704626 |
Enrolling by invitation |
University of California, Davis |
2020-12-31 |
| NCT00702065 |
A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment |
https://ClinicalTrials.gov/show/NCT00702065 |
Completed |
EMD Serono |
2010-10-31 |
| NCT00677768 |
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00677768 |
Completed |
Massachusetts General Hospital |
2015-11-30 |
| NCT00668473 |
Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT00668473 |
Completed |
University of Michigan |
2008-05-31 |
| NCT00667134 |
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT00667134 |
Completed |
University of Michigan |
2008-08-31 |
| NCT00620698 |
Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials |
https://ClinicalTrials.gov/show/NCT00620698 |
Completed |
Beth Israel Deaconess Medical Center |
2011-03-31 |
| NCT00598455 |
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations |
https://ClinicalTrials.gov/show/NCT00598455 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-09-30 |
| NCT00599274 |
Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00599274 |
Completed |
Biogen |
NA |
| NCT00552955 |
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women |
https://ClinicalTrials.gov/show/NCT00552955 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00544037 |
BENEFIT Extension Study |
https://ClinicalTrials.gov/show/NCT00544037 |
Completed |
Bayer |
2011-01-31 |
| NCT00537641 |
Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) |
https://ClinicalTrials.gov/show/NCT00537641 |
Completed |
Columbia University |
2010-07-31 |
| NCT00525343 |
Avonex 15 Year Long Term Follow-up Study |
https://ClinicalTrials.gov/show/NCT00525343 |
Completed |
Biogen |
NA |
| NCT00490906 |
Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00490906 |
Completed |
University of Kansas Medical Center |
2009-02-28 |
| NCT00492570 |
GER-009-06-AVX Early Therapy in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00492570 |
Completed |
Biogen |
2007-10-31 |
| NCT00483847 |
TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World |
https://ClinicalTrials.gov/show/NCT00483847 |
Completed |
Biogen |
2014-11-30 |
| NCT00477113 |
TYSABRI Global Observational Program in Safety |
https://ClinicalTrials.gov/show/NCT00477113 |
Completed |
Biogen |
2015-05-31 |
| NCT00468182 |
Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00468182 |
Completed |
Rutgers, The State University of New Jersey |
2011-12-31 |
| NCT00461396 |
Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron |
https://ClinicalTrials.gov/show/NCT00461396 |
Completed |
Bayer |
2009-06-30 |
| NCT00463710 |
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-Conventional MRI Measures in Patients With MS |
https://ClinicalTrials.gov/show/NCT00463710 |
Completed |
State University of New York at Buffalo |
NA |
| NCT00445367 |
Biobank For MS And Other Demyelinating Diseases |
https://ClinicalTrials.gov/show/NCT00445367 |
Active, not recruiting |
Accelerated Cure Project for Multiple Sclerosis |
2026-10-31 |
| NCT00439257 |
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron) |
https://ClinicalTrials.gov/show/NCT00439257 |
Completed |
VA Office of Research and Development |
NA |
| NCT00430599 |
The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00430599 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
NA |
| NCT00424359 |
Ambulation Study in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00424359 |
Completed |
Brown, Theodore R., M.D., MPH |
NA |
| NCT00406263 |
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls |
https://ClinicalTrials.gov/show/NCT00406263 |
Completed |
Barnes Retina Institute |
2010-10-31 |
| NCT00393588 |
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00393588 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00391352 |
fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls |
https://ClinicalTrials.gov/show/NCT00391352 |
Completed |
Waukesha Memorial Hospital |
2012-08-31 |
| NCT00377949 |
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients |
https://ClinicalTrials.gov/show/NCT00377949 |
Completed |
Georgetown University |
2016-01-31 |
| NCT00339976 |
Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT00339976 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00334516 |
Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT00334516 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00337402 |
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT00337402 |
Completed |
University Hospital, Clermont-Ferrand |
NA |
| NCT00325988 |
Biomarkers in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00325988 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00321568 |
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00321568 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00317564 |
Betaseron Pregnancy Registry |
https://ClinicalTrials.gov/show/NCT00317564 |
Completed |
Syneos Health |
2012-04-30 |
| NCT00317616 |
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study |
https://ClinicalTrials.gov/show/NCT00317616 |
Recruiting |
University of Miami |
2027-12-31 |
| NCT00302198 |
Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org |
https://ClinicalTrials.gov/show/NCT00302198 |
Completed |
Forbes Norris MDA/ALS Research Center |
2010-02-28 |
| NCT00288990 |
A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00288990 |
Completed |
Biogen |
NA |
| NCT00262314 |
Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT00262314 |
Completed |
EMD Serono |
2008-01-31 |
| NCT00232193 |
Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS |
https://ClinicalTrials.gov/show/NCT00232193 |
Completed |
Providence Multiple Sclerosis Center |
2008-12-31 |
| NCT00229502 |
Cognitive Effects of Immunomodulatory Drugs in MS |
https://ClinicalTrials.gov/show/NCT00229502 |
Completed |
University of Kansas Medical Center |
2011-09-30 |
| NCT00223457 |
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00223457 |
Completed |
University of Texas Southwestern Medical Center |
NA |
| NCT00206635 |
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00206635 |
Completed |
Bayer |
NA |
| NCT00203086 |
A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00203086 |
Completed |
Teva Pharmaceutical Industries |
2009-10-31 |
| NCT00136500 |
Clinical Research in ALS Study |
https://ClinicalTrials.gov/show/NCT00136500 |
Recruiting |
University of Miami |
2027-12-31 |
| NCT00099307 |
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00099307 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00094068 |
The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients |
https://ClinicalTrials.gov/show/NCT00094068 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00071435 |
Brain Function in Primary Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT00071435 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00819195 |
Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00819195 |
Completed |
University of California, San Francisco |
2012-09-30 |
| NCT00064909 |
MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT00064909 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00819000 |
Therapy Optimization in Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT00819000 |
Completed |
Teva Pharmaceutical Industries |
2012-12-31 |
| NCT00818038 |
A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function |
https://ClinicalTrials.gov/show/NCT00818038 |
Completed |
Biogen |
2011-03-31 |
| NCT00710645 |
Lido Workset Study |
https://ClinicalTrials.gov/show/NCT00710645 |
Completed |
University of California, Davis |
2012-06-30 |
| NCT00023075 |
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT00023075 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00617383 |
AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS |
https://ClinicalTrials.gov/show/NCT00617383 |
Completed |
The University of Texas Health Science Center, Houston |
2010-12-31 |
| NCT00015444 |
Screening and Natural History: Primary Lateral Sclerosis and Related Disorders |
https://ClinicalTrials.gov/show/NCT00015444 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00007722 |
Amyotrophic Lateral Sclerosis (ALS) Gulf War Study |
https://ClinicalTrials.gov/show/NCT00007722 |
Completed |
VA Office of Research and Development |
2003-03-31 |
| NCT00001975 |
Study of Skin Tumors in Tuberous Sclerosis |
https://ClinicalTrials.gov/show/NCT00001975 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001156 |
Assessment of Patients With Multiple Sclerosis (MS) |
https://ClinicalTrials.gov/show/NCT00001156 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |